Skip to content
Screener

Clover Health Investments CLOV Q2 2025 earnings

Reported August 5, 2025 · After market close

Revenue$477.6MBeat by $9.3M
EPS$0.03In line
Revenue estimate$468.3M
EPS estimate$0.03

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$740.3M
EPS estimate-$0.01

Financials

Q2 2025

Income statement

See full
Revenue$477.6M+34.1%
Operating income-$10.6M-247%
Net income-$10.6M-243%
EPS (diluted)-$0.02-300%

Balance sheet

See full
Cash & equivalents$188.6M-26.0%
Total equity$344.2M+5.9%
Total assets$575.0M-14.7%

Cash flow

See full
Operating cash flow--100%
CapEx$569.0K+43.3%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.45B+142%
P/S0.9×+0.4×

Profitability

See full
Operating margin-2.6%-1.1pp
Net margin-2.7%-1.1pp

Returns & leverage

See full
Return on equity-12.9%-5.1pp
Current ratio1.8×+0.1×

FAQ

When did Clover Health Investments report Q2 2025 earnings?
Clover Health Investments (CLOV) reported Q2 2025 earnings on August 5, 2025 after market close.
What were Clover Health Investments's Q2 2025 revenue and EPS?
Clover Health Investments reported revenue of $477.6M and eps of $0.03 for Q2 2025.
Did Clover Health Investments beat estimates in Q2 2025?
Revenue beat the consensus estimate of $468.3M by $9.3M. EPS beat the consensus estimate of $0.03 by $0.00.
How did Clover Health Investments's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 34.1% from $356.3M a year earlier and eps grew 200.0% from $0.01.
Where can I find Clover Health Investments's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001801170-25-000196) and the 10-Q periodic report (0001801170-25-000204) directly on SEC EDGAR. The filing index links above go to sec.gov.